Compare $ADTX vs $APVO | Chartloom

Compare

$ADTX vs $APVO

Aditxt Inc · Aptevo Therapeutics Inc

ADTX

Aditxt Inc

APVO

Aptevo Therapeutics Inc

Compare $ADTX vs $APVO

Comparing Aditxt Inc and Aptevo Therapeutics Inc

ADTXAditxt Inc

APVOAptevo Therapeutics Inc

ADTXAditxt Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-74.0%

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

-186.2%

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADTX

APVO

Detailed metrics comparison

ADTX

Aditxt Inc

APVO

Aptevo Therapeutics Inc

Market Cap

ADTX$10M

APVO$2M

Enterprise Value

ADTX$13M

APVO$-8M

Price

ADTX$0.01

APVO$1.79

P/E Ratio

ADTXN/A

APVON/A

P/S Ratio

ADTX693.04x

APVO0.25x

EV/Sales

ADTX903.97x

APVO-0.51x

EV/EBITDA

ADTX0.00x

APVO-0.91x

P/B Ratio

ADTX0.53x

APVO0.53x

P/FCF Ratio

ADTXN/A

APVON/A

EV/FCF

ADTX-0.70x

APVO0.30x

PEG Ratio

ADTXN/A

APVON/A

Forward P/E (NTM)

ADTXN/A

APVON/A

Forward P/S (NTM)

ADTXN/A

APVON/A

Revenue (TTM)

ADTX$14K

APVO$0

Revenue Growth (YoY)

ADTX-74.0%

APVON/A

Forward Rev Growth

ADTX0.0%

APVO206.8%

Gross Margin (TTM)

ADTX20.1%

APVO51.4%

Operating Margin (TTM)

ADTX0.0%

APVO0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

APVO0.0%

Net Margin (TTM)

ADTX-370408.3%

APVO0.0%

FCF Margin (TTM)

ADTX-129012.5%

APVON/A

Net Income (TTM)

ADTX$-53M

APVO$-28M

FCF (TTM)

ADTX$-19M

APVO$-25M

EPS (TTM)

ADTX-$2,640.53

APVO-$23.47

ROE (TTM)

ADTX-15077.0%

APVO-20149.0%

ROA (TTM)

ADTX-27739.0%

APVO-11921.0%

ROIC (TTM)

ADTX-11833.0%

APVO-20149.0%

Cash

ADTX$269K

APVO$10M

Debt

ADTX$3M

APVO$0

Net Cash/Debt

ADTX$-3M

APVO$10M

Current Ratio (TTM)

ADTX0.06x

APVO2.08x

Quick Ratio (TTM)

ADTX0.02x

APVO1.98x

Debt/Equity (TTM)

ADTX0.33x

APVO0.00x

Debt/Assets (TTM)

ADTX0.0%

APVO0.0%

Interest Coverage (TTM)

ADTXN/A

APVON/A

Net Debt/EBITDA (TTM)

ADTX0.00x

APVO0.00x

Beta

ADTX1.31

APVO1.68

52W Performance

ADTX-100.0%

APVO-94.2%

YTD Performance

ADTX-100.0%

APVO-80.9%

% from 52W High

ADTX-100.0%

APVO-94.6%

% from 52W Low

ADTXN/A

APVO30.7%

Asset Turnover (TTM)

ADTX0.00x

APVO0.22x

FCF Yield (TTM)

ADTX-186.2%

APVO-1132.6%

Earnings Yield (TTM)

ADTX-534.5%

APVO-1254.8%

Dividend Yield (TTM)

ADTXN/A

APVON/A

Rule of 40

ADTX-129,086.5

APVO0.0

EV/GP/RG

ADTXN/A

APVON/A

Ticker research

View ADTX research View APVO research

Metric	ADTX Aditxt Inc	APVO Aptevo Therapeutics Inc
Market & Valuation
Market Cap	$10M	$2M
Enterprise Value	$13M	$-8M
Price	$0.01	$1.79
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	0.25x
EV/Sales	903.97x	-0.51x
EV/EBITDA	0.00x	-0.91x
P/B Ratio	0.53x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	0.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$0
Revenue Growth (YoY)	-74.0%	N/A
Forward Rev Growth	0.0%	206.8%
Profitability
Gross Margin (TTM)	20.1%	51.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	0.0%
Net Margin (TTM)	-370408.3%	0.0%
FCF Margin (TTM)	-129012.5%	N/A
Net Income (TTM)	$-53M	$-28M
FCF (TTM)	$-19M	$-25M
EPS (TTM)	-$2,640.53	-$23.47
ROE (TTM)	-15077.0%	-20149.0%
ROA (TTM)	-27739.0%	-11921.0%
ROIC (TTM)	-11833.0%	-20149.0%
Financial Health
Cash	$269K	$10M
Debt	$3M	$0
Net Cash/Debt	$-3M	$10M
Current Ratio (TTM)	0.06x	2.08x
Quick Ratio (TTM)	0.02x	1.98x
Debt/Equity (TTM)	0.33x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	1.68
52W Performance	-100.0%	-94.2%
YTD Performance	-100.0%	-80.9%
% from 52W High	-100.0%	-94.6%
% from 52W Low	N/A	30.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-186.2%	-1132.6%
Earnings Yield (TTM)	-534.5%	-1254.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View APVO research

Valuation

P/S Ratio

APVO

0.25x

ADTX

693.04x

EV/FCF

ADTX

-0.70x

APVO

0.30x

Growth & revenue

Revenue Growth TTM

ADTX

-74.0%

Forward Revenue Growth

APVO

206.8%

ADTX

0.0%

Profitability & performance

Gross Margin

APVO

51.4%

ADTX

20.1%

ROE

ADTX

-15077.0%

APVO

-20149.0%

FCF Yield %

ADTX

-186.2%

APVO

-1132.6%

52-Week Performance

APVO

-94.2%

ADTX

-100.0%

Detailed metrics comparison

ADTX

Aditxt Inc

APVO

Aptevo Therapeutics Inc

Market Cap

ADTX$10M

APVO$2M

Enterprise Value

ADTX$13M

APVO$-8M

Price

ADTX$0.01

APVO$1.79

P/E Ratio

ADTXN/A

APVON/A

P/S Ratio

ADTX693.04x

APVO0.25x

EV/Sales

ADTX903.97x

APVO-0.51x

EV/EBITDA

ADTX0.00x

APVO-0.91x

P/B Ratio

ADTX0.53x

APVO0.53x

P/FCF Ratio

ADTXN/A

APVON/A

EV/FCF

ADTX-0.70x

APVO0.30x

PEG Ratio

ADTXN/A

APVON/A

Forward P/E (NTM)

ADTXN/A

APVON/A

Forward P/S (NTM)

ADTXN/A

APVON/A

Revenue (TTM)

ADTX$14K

APVO$0

Revenue Growth (YoY)

ADTX-74.0%

APVON/A

Forward Rev Growth

ADTX0.0%

APVO206.8%

Gross Margin (TTM)

ADTX20.1%

APVO51.4%

Operating Margin (TTM)

ADTX0.0%

APVO0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

APVO0.0%

Net Margin (TTM)

ADTX-370408.3%

APVO0.0%

FCF Margin (TTM)

ADTX-129012.5%

APVON/A

Net Income (TTM)

ADTX$-53M

APVO$-28M

FCF (TTM)

ADTX$-19M

APVO$-25M

EPS (TTM)

ADTX-$2,640.53

APVO-$23.47

ROE (TTM)

ADTX-15077.0%

APVO-20149.0%

ROA (TTM)

ADTX-27739.0%

APVO-11921.0%

ROIC (TTM)

ADTX-11833.0%

APVO-20149.0%

Cash

ADTX$269K

APVO$10M

Debt

ADTX$3M

APVO$0

Net Cash/Debt

ADTX$-3M

APVO$10M

Current Ratio (TTM)

ADTX0.06x

APVO2.08x

Quick Ratio (TTM)

ADTX0.02x

APVO1.98x

Debt/Equity (TTM)

ADTX0.33x

APVO0.00x

Debt/Assets (TTM)

ADTX0.0%

APVO0.0%

Interest Coverage (TTM)

ADTXN/A

APVON/A

Net Debt/EBITDA (TTM)

ADTX0.00x

APVO0.00x

Beta

ADTX1.31

APVO1.68

52W Performance

ADTX-100.0%

APVO-94.2%

YTD Performance

ADTX-100.0%

APVO-80.9%

% from 52W High

ADTX-100.0%

APVO-94.6%

% from 52W Low

ADTXN/A

APVO30.7%

Asset Turnover (TTM)

ADTX0.00x

APVO0.22x

FCF Yield (TTM)

ADTX-186.2%

APVO-1132.6%

Earnings Yield (TTM)

ADTX-534.5%

APVO-1254.8%

Dividend Yield (TTM)

ADTXN/A

APVON/A

Rule of 40

ADTX-129,086.5

APVO0.0

EV/GP/RG

ADTXN/A

APVON/A

Ticker research

View ADTX research View APVO research

Metric	ADTX Aditxt Inc	APVO Aptevo Therapeutics Inc
Market & Valuation
Market Cap	$10M	$2M
Enterprise Value	$13M	$-8M
Price	$0.01	$1.79
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	0.25x
EV/Sales	903.97x	-0.51x
EV/EBITDA	0.00x	-0.91x
P/B Ratio	0.53x	0.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	0.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$0
Revenue Growth (YoY)	-74.0%	N/A
Forward Rev Growth	0.0%	206.8%
Profitability
Gross Margin (TTM)	20.1%	51.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	0.0%
Net Margin (TTM)	-370408.3%	0.0%
FCF Margin (TTM)	-129012.5%	N/A
Net Income (TTM)	$-53M	$-28M
FCF (TTM)	$-19M	$-25M
EPS (TTM)	-$2,640.53	-$23.47
ROE (TTM)	-15077.0%	-20149.0%
ROA (TTM)	-27739.0%	-11921.0%
ROIC (TTM)	-11833.0%	-20149.0%
Financial Health
Cash	$269K	$10M
Debt	$3M	$0
Net Cash/Debt	$-3M	$10M
Current Ratio (TTM)	0.06x	2.08x
Quick Ratio (TTM)	0.02x	1.98x
Debt/Equity (TTM)	0.33x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	1.68
52W Performance	-100.0%	-94.2%
YTD Performance	-100.0%	-80.9%
% from 52W High	-100.0%	-94.6%
% from 52W Low	N/A	30.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-186.2%	-1132.6%
Earnings Yield (TTM)	-534.5%	-1254.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View APVO research